Vytrus Biotech S.A. (VYT) — Net Asset Quality Index
Vytrus Biotech S.A. (VYT) has a Net Asset Quality Index of 70.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €14.66 Million minus total liabilities of €4.35 Million yields net assets of €10.31 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read VYT total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Vytrus Biotech S.A. Net Asset Quality Index Over Time (2020–2025)
This chart shows how Vytrus Biotech S.A.'s Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 70.3%, representing net assets of €10.31 Million against total assets of €14.66 Million EUR. For live market cap and overall valuation, see market value of Vytrus Biotech S.A..
Annual Net Asset Quality Index for Vytrus Biotech S.A. (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Vytrus Biotech S.A. from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Vytrus Biotech S.A. to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.3% | €10.31 Million | €14.66 Million | €4.35 Million | ▲ +4.8 pp |
| 2024 | 65.5% | €7.29 Million | €11.13 Million | €3.84 Million | ▲ +8.7 pp |
| 2023 | 56.8% | €5.29 Million | €9.31 Million | €4.02 Million | ▼ -2.6 pp |
| 2022 | 59.4% | €4.75 Million | €8.00 Million | €3.25 Million | ▲ +0.2 pp |
| 2021 | 59.2% | €4.25 Million | €7.18 Million | €2.93 Million | ▲ +1.0 pp |
| 2020 | 58.1% | €3.61 Million | €6.21 Million | €2.60 Million | — |